{"id":"https://openalex.org/W4361920139","doi":"https://doi.org/10.1158/1078-0432.22461648.v1","title":"Supplemental Figure 1. from Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities","display_name":"Supplemental Figure 1. from Toxicity Attribution in Phase I Trials: Evaluating the Effect of Dose on the Frequency of Related and Unrelated Toxicities","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361920139","doi":"https://doi.org/10.1158/1078-0432.22461648.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22461648.v1","doi":"https://doi.org/10.1158/1078-0432.22461648.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22461648.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22461648.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023924283","display_name":"Anne A. Eaton","orcid":"https://orcid.org/0000-0001-5900-9745","observed_orcids":["https://orcid.org/0000-0001-5900-9745"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anne Eaton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001429608","display_name":"Alexia E. Iasonos","orcid":"https://orcid.org/0000-0003-0471-8477","observed_orcids":["https://orcid.org/0000-0003-0471-8477"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexia Iasonos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034595315","display_name":"Mrinal M. Gounder","orcid":"https://orcid.org/0000-0001-8468-0119","observed_orcids":["https://orcid.org/0000-0001-8468-0119"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mrinal M. Gounder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085328031","display_name":"Erika G. Pamer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Erika G. Pamer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063199354","display_name":"Alexander Edward Dela Cruz Drilon","orcid":"https://orcid.org/0000-0001-6806-9061","observed_orcids":["https://orcid.org/0000-0001-6806-9061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexander Drilon","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037271504","display_name":"Diana Vulih","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Vulih","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Gary L. Smith","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary L. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080736692","display_name":"S. Percy Ivy","orcid":"https://orcid.org/0000-0001-7747-072X","observed_orcids":["https://orcid.org/0000-0001-7747-072X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Percy Ivy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073323475","display_name":"David R. Spriggs","orcid":"https://orcid.org/0000-0003-2174-4992","observed_orcids":["https://orcid.org/0000-0003-2174-4992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David R. Spriggs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5068193017","display_name":"David Michael Hyman","orcid":"https://orcid.org/0000-0001-8150-9762","observed_orcids":["https://orcid.org/0000-0001-8150-9762"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David M. Hyman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.9926999807357788,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytotoxic-drugs","display_name":"cytotoxic drugs","score":0.7549999952316284},{"id":"https://openalex.org/keywords/molecularly-targeted-agents","display_name":"molecularly targeted agents","score":0.8769999742507935},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7540000081062317},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.7736032009124756},{"id":"https://openalex.org/C143299363","wikidata":"https://www.wikidata.org/wiki/Q900584","display_name":"Attribution","level":2,"score":0.7312501668930054},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.6187383532524109},{"id":"https://openalex.org/C119043178","wikidata":"https://www.wikidata.org/wiki/Q320723","display_name":"Covariate","level":2,"score":0.5980536341667175},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.48459041118621826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3817880153656006},{"id":"https://openalex.org/C105795698","wikidata":"https://www.wikidata.org/wiki/Q12483","display_name":"Statistics","level":1,"score":0.35511094331741333},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.34287768602371216},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.27735522389411926},{"id":"https://openalex.org/C77805123","wikidata":"https://www.wikidata.org/wiki/Q161272","display_name":"Social psychology","level":1,"score":0.16125249862670898}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22461648.v1","doi":"https://doi.org/10.1158/1078-0432.22461648.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22461648.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22461648.v1","doi":"https://doi.org/10.1158/1078-0432.22461648.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22461648.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8371999859809875,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4361955030","https://openalex.org/W1757759434","https://openalex.org/W2598707309","https://openalex.org/W1919987368","https://openalex.org/W2314629780","https://openalex.org/W2181507827","https://openalex.org/W1978249865","https://openalex.org/W2938862724","https://openalex.org/W4399585354","https://openalex.org/W2804489715"],"abstract_inverted_index":{"Dose-toxicity":[0],"curves":[1],"by":[2],"agent":[3],"class":[4],"(cytotoxic":[5],"or":[6,27,48],"molecular)":[7],"and":[8,35,56,76],"attribution":[9],"(2-tier":[10],"system).":[11],"Black":[12],"points":[13,38],"represent":[14,39,59],"the":[15,32,40,53,80],"proportion":[16,41],"of":[17,42,67],"patients":[18,43],"in":[19],"a":[20,60,73],"dose":[21,70],"group":[22],"experiencing":[23,44],"grade":[24,45],"{greater":[25,46],"than":[26,47],"equal":[28,49],"to}1":[29],"toxicity":[30,51],"with":[31,65],"specified":[33,54],"category":[34,55],"attribution.":[36,57],"Red":[37],"to}3":[50],"within":[52],"Lines":[58],"fitted":[61],"logistic":[62],"regression":[63],"curve":[64],"%":[66],"maximum":[68],"administered":[69],"(MAD)":[71],"as":[72],"continuous":[74],"covariate":[75],"p-values":[77],"are":[78],"from":[79],"same":[81],"model.":[82]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2023-04-05T00:00:00"}